PER 1.35% 7.5¢ percheron therapeutics limited

Ann: Positive PDCO opinion and A$20m Placement, page-69

  1. 4,683 Posts.
    lightbulb Created with Sketch. 1086
    RC,

    The market is a forward looking instrument.

    The market will value the unique opportunity here...way ahead of revenue!

    ATL1102 will be a First in Class + Best in Class drug...protected by ODD for 7 - 10 years.

    We are talking $4B per year market just for non-ambulant boys (EU/US).

    Say they attain only 50% of the market - that is still $2B per year revenue.

    Currently we are sitting at sub $150m market cap.

    So...soon we start the value accretion in line with FA progress.

    The only way is up...baby...for you and me!
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
0.001(1.35%)
Mkt cap ! $67.61M
Open High Low Value Volume
7.7¢ 7.8¢ 7.4¢ $24.63K 325.4K

Buyers (Bids)

No. Vol. Price($)
2 142779 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8181 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.